1. Home
  2. TFX vs DVA Comparison

TFX vs DVA Comparison

Compare TFX & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFX
  • DVA
  • Stock Information
  • Founded
  • TFX 1943
  • DVA 1994
  • Country
  • TFX United States
  • DVA United States
  • Employees
  • TFX N/A
  • DVA N/A
  • Industry
  • TFX Medical/Dental Instruments
  • DVA Misc Health and Biotechnology Services
  • Sector
  • TFX Health Care
  • DVA Health Care
  • Exchange
  • TFX Nasdaq
  • DVA Nasdaq
  • Market Cap
  • TFX 10.4B
  • DVA 12.2B
  • IPO Year
  • TFX N/A
  • DVA 1995
  • Fundamental
  • Price
  • TFX $242.49
  • DVA $164.02
  • Analyst Decision
  • TFX Buy
  • DVA Hold
  • Analyst Count
  • TFX 9
  • DVA 5
  • Target Price
  • TFX $261.86
  • DVA $153.60
  • AVG Volume (30 Days)
  • TFX 263.6K
  • DVA 710.5K
  • Earning Date
  • TFX 10-31-2024
  • DVA 11-05-2024
  • Dividend Yield
  • TFX 0.56%
  • DVA N/A
  • EPS Growth
  • TFX N/A
  • DVA 85.58
  • EPS
  • TFX 5.56
  • DVA 9.38
  • Revenue
  • TFX $3,007,838,000.00
  • DVA $12,524,356,000.00
  • Revenue This Year
  • TFX $5.09
  • DVA $6.03
  • Revenue Next Year
  • TFX $5.85
  • DVA $4.13
  • P/E Ratio
  • TFX $43.68
  • DVA $17.45
  • Revenue Growth
  • TFX 3.76
  • DVA 6.69
  • 52 Week Low
  • TFX $177.63
  • DVA $71.51
  • 52 Week High
  • TFX $257.85
  • DVA $166.04
  • Technical
  • Relative Strength Index (RSI)
  • TFX 53.32
  • DVA 70.78
  • Support Level
  • TFX $239.78
  • DVA $160.03
  • Resistance Level
  • TFX $246.64
  • DVA $166.04
  • Average True Range (ATR)
  • TFX 4.38
  • DVA 3.97
  • MACD
  • TFX -0.90
  • DVA 0.72
  • Stochastic Oscillator
  • TFX 30.45
  • DVA 88.72

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Share on Social Networks: